Otsuka America Inc.

News & Analysis

otsuka america inc. - All News and Analysis

• Santarus Provides Termination Notice to Otsuka America Pharmaceutical for ZEGERID Co-Promotion Agreement

  - 2008-04-15

  SAN DIEGO -- Santarus, Inc. (NASDAQ: SNTS), a specialty pharmaceutical company, today announced that it has provided notice to Otsuka America Pharmaceutical, Inc. of its intent to terminate their co-promotion agreement effective August 13, 2008, or earlier as the parties may mutually agree. Under the co-promotion agreement, Otsuka America has...

  Tags: Otsuka America Inc.

• PhereSys™ Therapeutics to Participate in Otsuka America Pharmaceutical's Clinical Trial for the Treatment of Ulcerative Colitis

  - 2005-08-03

  EL DORADO HILLS, Calif. -- PhereSys Therapeutics Corporation ("PhereSys") announced today its participation in a clinical trial sponsored by Otsuka America Pharmaceutical, Inc. ("OAPI") to evaluate the safety and effectiveness of the AdacolumnR Apheresis System ("AdacolumnR") as a potential treatment for symptoms of ulcerative colitis. Ulcerative colitis is the most...

  Tags: Otsuka America Inc.

• Otsuka America Pharmaceutical Receives Frost & Sullivan's 2004 Product Innovation of the Year Award for Antipsychotic Medications

  - 2004-10-04

  PALO ALTO, Calif. -- In a recent study on U.S. Antipsychotic Medications Markets, Frost & Sullivan highlighted the success of Otsuka America Pharmaceutical, Inc. OAPI in developing and commercializing AbilifyR aripiprazole. Because Abilify has a unique pharmacology among atypical antipsychotics and has demonstrated proven efficacy with a comprehensive tolerability and...

  Tags: Frost & Sullivan

• HemaCare Announces Investigational Site Agreement with Otsuka America Pharmaceutical and Termination of Dartmouth Blood Center Management Contract

  - 2004-06-17

  LOS ANGELES -- HemaCare Corporation (OTCBB:HEMA) announced today that Otsuka America Pharmaceutical, Inc. ("Otsuka") has expanded its contract with HemaCare to perform all of the set-up, verification and training services associated with Otsuka's clinical trials of the AdacolumnR Apheresis System, an investigational device being studied for the treatment of various...

  Tags: Otsuka America Inc.